| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $205K | — |
| SG&A Expense | $732K | — |
| Net Income | -$938K | — |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76K | -62.6% |
| Current Assets | $100K | -50.7% |
| Total Assets | $124K | -38.6% |
| Current Liabilities | $36K | +23.3% |
| Total Liabilities | $43K | +45.0% |
| Stockholders' Equity | $82K | -52.7% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$645K | — |
| Financing Cash Flow | $519K | — |